Dumas, P. Y., Maiti, A., Peterlin, P., Morillo, D., Torregrosa-Diaz, J. M., Ulrickson, M., Penedo, A., Gassart, A. D., Valentin, E., Mairesse, M., Brune, P., Lemmens, K., Olive, D., Braun, S., Daver, N. G., Garciaz, S. (2025). γ9δ2 T-cell activation (γδTCA) with ICT01 combined with azacitidine-venetoclax (AV) for older/unfit adults with newly diagnosed (ND) AML: Preliminary efficacy and dose selection in phase 1/2 study EVICTION.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6507